Elicio entered into an at-the-market equity distribution agreement with B. Riley Securities, JonesTrading Institutional Services and Ladenburg Thalmann to sell up to USD 100 million of its common stock. The shares may be sold from time to time through Nasdaq or other trading markets, with the agents using commercially reasonable efforts. Elicio will pay the agents a 3% commission on gross sales proceeds for shares sold under the program. The company also terminated its prior JonesTrading sales agreement for an at-the-market program of up to USD 40 million, with no termination penalties.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elicio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001601485-26-000032), on March 16, 2026, and is solely responsible for the information contained therein.
Comments